000 | 01267 a2200349 4500 | ||
---|---|---|---|
005 | 20250515050926.0 | ||
264 | 0 | _c20070104 | |
008 | 200701s 0 0 eng d | ||
022 | _a1054-3406 | ||
024 | 7 |
_a10.1080/10543400600825645 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aJung, Sin-Ho | |
245 | 0 | 0 |
_aP-value calculation for multistage phase II cancer clinical trials. _h[electronic resource] |
260 |
_bJournal of biopharmaceutical statistics _c2006 |
||
300 |
_a765-75; discussion 777-83 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aClinical Trials, Phase II as Topic _xstatistics & numerical data |
650 | 0 | 4 | _aEndpoint Determination |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLikelihood Functions |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 | _aResearch Design |
650 | 0 | 4 | _aStochastic Processes |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aOwzar, Kouros | |
700 | 1 | _aGeorge, Stephen L | |
700 | 1 | _aLee, Taiyeong | |
773 | 0 |
_tJournal of biopharmaceutical statistics _gvol. 16 _gno. 6 _gp. 765-75; discussion 777-83 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1080/10543400600825645 _zAvailable from publisher's website |
999 |
_c16716746 _d16716746 |